uk titans 50 50 memory income autocall february …€¦ · uk titans 50-50 memory income autocall...
TRANSCRIPT
Issuer and Counterparty: Natixis
Credit Ratings: Fitch: A, Moody’s: A2, S&P: A Source: Bloomberg 01.12.2017
Maximum Term: 6 years
Investment Structure: Quarterly Memory Income Autocall
Autocall opportunities: Quarterly (First observation at 3 months)
Autocall Trigger: 100% of initial level
Memory Income Rate: GBP = 2.00% Quarterly
Income Trigger: 50% of initial level
Capital Risk: Not capital protected
Capital Protection Barrier: 50% Final level (European style)
Underlying Basket Bloomberg Code
AstraZeneca PLC AZN LN Equity
Centrica PLC CNA LN Equity
HSBC Holdings PLC HSBA LN Equity
BP PLC BP/ LN Euity
Subscription Period: 01 Dec 2017 – 31 Jan 2018 (4.30pm UK Time)
Issue Price: 100%
Strike Date: 01 February 2018
Issue Date: 08 February 2018
1st Coupon Observation: 01 May 2018
1st Autocall Observation: 01 May 2018
Final Observation: 01 February 2024
Maturity Date: 08 February 2024
Denominations: 1,000 then lots of 1
ISIN: GBP = XS1636946383
Natixis
UK Titans 50-50 Memory Income Autocall February 2018
Factsheet
PRODUCT FACTS & FEATURES
KEY INFORMATION
IDAD Limited is Authorised and Regulated by the Financial Conduct Authority FCA FRN 740499. No part of this publication may be reproduced, copied or distributed without the prior permission in writing of IDAD. Returns from the structured products are at risk in the event of any of the institutions who provide securities for these products default on their financial obligations. All investors should seek advice from a suitably authorised financial adviser and investment must be made via an authorised counterparty.
INVESTMENT DESCRIPTION
A 6 year investment linked to the performance of 4 large cap UK stocks.
If on any of the quarterly observation dates, including the final observation, the closing levels of all the underlyings are at or above 50% of their initial levels, the income will be paid plus any previously missed income payments.
This investment will autocall and mature early if all underlyings are equal to or above their initial levels on any quarterly observation date starting at 3 months. If early maturity occurs, full capital is returned and the investment will end. If early maturity does not occur the investment will continue to the final observation date.
At the final observation date, if all underlyings are at or above 50% of their initial levels, then full capital is returned. If any underlying is below 50% of its original level, capital return will be reduced on a 1-for-1 basis. For example if the worst performing underlying has fallen to 40% of its original level, 40% of the capital will be returned.
BENEFITS
Opportunity for regular income payments even where the underlyings show significant falls.
A memory feature, whereby income previously unpaid, will be included when the income trigger is next activated.
Autocall feature potentially shortens the investment term and is triggered by minimal growth.
Early maturity provides an opportunity to re-assess client’s wealth strategy.
Daily pricing.
RISKS
The return is limited to the pre-defined investment terms.
The income payment is conditional upon the underlying performance.
There is a risk to capital should one of the underlyings breach the capital protection barrier on its Final Observation Date or in the event of an issuer default.
Should investors need to sell their investment before maturity, the trading price will likely mean they get back less than they invested.
Observations
1 to 23 Early Maturity =
Full capital returned
Income paid (plus any missed
Income)
Yes Yes
Are all underlyings at or above
50% of their initial levels? Income paid (plus any missed Income) and full capital returned
Final Observation
No = No income paid No = Investment Continues
Are all underlyings at or above
100% of their initial levels?
If any are below 50%, capital is reduced on 1-for-1 basis
in-line with the worst performing underlying.
No = No income paid
Yes
HOW THE INVESTMENT WORKS
Are all underlyings at or above
50% of their initial levels?
Natixis
UK Titans 50-50 Memory Income Autocall February 2018
Factsheet
IDAD Limited is Authorised and Regulated by the Financial Conduct Authority FCA FRN 740499. No part of this publication may be reproduced, copied or distributed without the prior permission in writing of IDAD. Returns from the structured products are at risk in the event of any of the institutions who provide securities for these products default on their financial obligations. All investors should seek advice from a suitably authorised financial adviser and investment must be made via an authorised counterparty.
Observation Dates (some payment dates may vary if a bank holiday occurs).
SUITABILITY This product may be suitable for investors who:
Are seeking the opportunity for higher returns than current cash rates at the time this product was launched.
Are seeking income rather than growth.
Understand and accept there is a risk to capital and how the Capital Protection Barrier works.
Understand the impact of global economic issues and how they will affect the product.
Understand the criteria which will determine the income payments.
Are looking to invest for the medium to long term, being happy to remain invested until maturity.
Can afford to have their cash invested for the full term of the Product.
Wish to use this investment as part of a well-diversified portfolio.
Understand that the returns are pre-defined and that they will forgo any growth in the underlyings which exceeds the fixed level available with this investment product.
Understand the risk to capital in the event of a counterparty default.
Should they need to sell their investment before maturity, accept that the trading price will likely mean they get back less than they invested.
Appreciate that income payments are conditional but understand that the memory feature can deliver previously missed income payments.
IDAD was established in 2002 and our approach from the outset, is what we call the "IDAD Difference”. The selection of the investments we offer is not decided in terms of profitability alone and when developing investment products, we favour evidence over dogma. We are happy to work with advisers and product providers alike to deliver a range of investment options to suit differing client wealth strategies. We’re proud of our approach to business as well as the investments delivered as a result of the "IDAD Difference”. We are committed to building upon our reputation for bringing benefits to all involved in the investment process, but most importantly to the clients.
Natixis: Natixis SA offers corporate, investment and financial services. The Bank services companies, financial institutions and
institutional investors. Natixis offers wholesale banking in the form of advising and financing, investment solutions in the form of asset
management, insurance, private banking and private equity, as well as other specialised financial services. Source: Bloomberg 01.12.2017
RATIONALE
Structured products are becoming increasingly popular for investors due to the wide variety of payoffs and levels of protection that can be achieved by the different types of structures that are available.
The opportunity for an income stream can be of key importance to investors as part of their wealth planning. The probability of an income payment being triggered is increased with this investment as an underlying needs to show a fall of 50% from its initial level on any observation date before the income stream is disrupted.
The investment also benefits from a memory feature so that if any income payments have missed being paid, they will catch-up the next time all underlyings are above 50% of their initial levels on an observation date.
These four underlyings have been selected in order to support the anticipated delivery of that income.
The autocall payoff can bring an early return of capital allowing the opportunity for a re-assessment of investment strategy. The value of this feature cannot be underestimated as it brings with it the opportunity to secure capital value, as well as the chance to take advantage of future market trends.
To manage the capital risk, a final level barrier set at 50% means an underlying must fall by more than 50% over 6 years before capital is at risk.
Observation Date Payment Date Income Trigger Autocall Trigger
Observation 1 01 May 2018 08 May 2018 50% 100%
Observation 2 01 August 2018 08 August 2018 50% 100%
Observation 3 01 November 2018 08 November 2018 50% 100%
Observation 4 01 February 2019 08 February 2019 50% 100%
Observation 5 01 May 2019 08 May 2019 50% 100%
Observation 6 01 August 2019 08 August 2019 50% 100%
Observation 7 01 November 2019 08 November 2019 50% 100%
Observation 8 03 February 2020 10 February 2020 50% 100%
Observation 9 01 May 2020 08 May 2020 50% 100%
Observation 10 03 August 2020 10 August 2020 50% 100%
Observation 11 02 November 2020 09 November 2020 50% 100%
Observation 12 01 February 2021 08 February 2021 50% 100%
Observation 13 04 May 2021 11 May 2021 50% 100%
Observation 14 02 August 2021 09 August 2021 50% 100%
Observation 15 01 November 2021 08 November 2021 50% 100%
Observation 16 01 February 2022 08 February 2022 50% 100%
Observation 17 03 May 2022 10 May 2022 50% 100%
Observation 18 01 August 2022 08 August 2022 50% 100%
Observation 19 01 November 2022 08 November 2022 50% 100%
Observation 20 01 February 2023 08 February 2023 50% 100%
Observation 21 02 May 2023 09 May 2023 50% 100%
Observation 22 01 August 2023 08 August 2023 50% 100%
Observation 23 01 November 2023 08 November 2023 50% 100%
Final Observation 01 February 2024 08 February 2024 50% 50% European Barrier
Natixis
UK Titans 50-50 Memory Income Autocall February 2018
Factsheet
THE UNDERLYINGS
AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia and infection.
Centrica PLC is an integrated energy company offering a wide range of home and business energy solutions. The Company sources, generates, processes, stores, trades, saves, and supplies energy and provides a range of related services.
HSBC Holdings PLC is the holding company for the HSBC Group. The Company provides a variety of international banking and
financial services, including retail and corporate banking, trade, trusteeship, securities, custody, capital markets, treasury, private and
investment banking, and insurance. HSBC Holdings operates worldwide.
BP PLC is an oil and petrochemicals company. The Company explores for and produces oil and natural gas, refines, markets, and
supplies petroleum products, generates solar energy, and manufactures and markets chemicals. BP’s chemicals include terephthalic acid,
acetic acid, acrylonitrile, ethylene and polyethylene. Source: Bloomberg 01.12.2017
Past performance is not a reliable indicator of future performance and should not be used to assess the future returns or risks Source: Bloomberg 01.12.2017, Data period: 30.11.2001 to 30.11.2017
MOVEMENT IN THE UNDERLYINGS OVER A 16 YEAR PERIOD
16 Year Back-Testing
Back-testing shows how the investment would have performed historically using data from previous potential strike dates and observations. Although past performance is not an indication of future performance, it can give a factual insight into how the investment would have performed historically.
This 16 year back-test shows the historical data for a full 10 years of 6 year products that could reach the full term.
Of the 2,501 scenarios tested, 39.86% would reach the full term without autocalling and none of these would have breached the 50% final level barrier.
Every coupon observation has also been tested, and out of all 2,501 scenarios tested, 100% of the available coupons would have been paid thanks to the Memory Income feature.
Total Number
Tested
% Matured
Early
% To Reach
Final Date
% That Returned
Full Capital
% Barrier
Breach
% Of Coupons
Paid
Average Historic
Return GBP
2501 60.14% 39.86% 100% 0% 100% 8.00% p.a.
IDAD Limited is Authorised and Regulated by the Financial Conduct Authority FCA FRN 740499. No part of this publication may be reproduced, copied or distributed without the prior permission in writing of IDAD. Returns from the structured products are at risk in the event of any of the institutions who provide securities for these products default on their financial obligations. All investors should seek advice from a suitably authorised financial adviser and investment must be made via an authorised counterparty.
Autocall Test Autocalled % Autocall Test Autocalled % Autocall Test Autocalled % Autocall Test Autocalled %
3 Months 357 14.27% 21 Months 119 4.76% 39 Months 12 0.48% 57 Months 14 0.56%
6 Months 239 9.56% 24 Months 126 5.04% 42 Months 10 0.40% 60 Months 0 0.00%
9 Months 126 5.04% 27 Months 45 1.80% 45 Months 4 0.16% 63 Months 0 0.00%
12 Months 86 3.44% 30 Months 78 3.12% 48 Months 4 0.16% 66 Months 0 0.00%
15 Months 71 2.84% 33 Months 42 1.68% 51 Months 27 1.08% 69 Months 0 0.00%
18 Months 104 4.16% 36 Months 10 0.40% 54 Months 30 1.20%
-60%
-40%
-20%
0%
20%
40%
60%
80%
100%
AstraZeneca PLC Centrica PLC HSBC Holdings PLC BP PLC
For further information please contact IDAD at:
Bellamy House, Winton Road, Petersfield, Hampshire. GU32 3HA
email: [email protected] telephone: +44(0)1730 263943 or visit our website www.idad.biz
DISCLAIMERS
This factsheet constitutes a financial promotion and has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act
2000 by IDAD Limited which is Authorised and Regulated by the Financial Conduct Authority FCA FRN 740499. All information, including prices, analytical
data and opinions contained within this factsheet are believed to be correct, accurate and derived from reliable sources as at the date of the factsheet. The
information within this factsheet does not take into account the specific investment objective or financial situation of any person. This material should be
read and understood by the investor. If the investor is not a professional client or eligible counterparty as defined by the FCA or is considered a retail
investor, they should seek suitable financial advice before investing, to ascertain the full risks and terms associated with the investment. All investments
must be made via an authorised counterparty. All rights reserved. No part of this publication may be reproduced, copied or distributed without the prior
permission in writing of IDAD. Investments may go up or down in value and you may lose some or all of the amount invested. Past performance is not
necessarily a guide for the future. Returns from the structured products are at risk in the event of any of the institutions who provide securities for these
products default on their financial obligations.
Fees of up to 0.6% p.a. for the maximum term of the investment may be paid by the Issuer to cover marketing, distribution and advice costs. The fees have
been fully accounted for in the calculation of the Product’s structure. For example, this means that an investment of £10,000 will have any income/growth
payments and capital protection based on the full £10,000.
Any financial adviser shall fully disclose to its clients the existence, nature and amount of all fees and commissions it receives in respect of sales of the
Note. They must also confirm any such fee or commission complies with all applicable laws and regulations in all relevant jurisdictions and its receipt does
not conflict with applicable regulation or any duty to act in the best interest of any person to whom the professional financial adviser owes any such duty.
This sales brochure has not been prepared or reviewed by the Issuing Bank, the Issuer of the underlying securities or any of its affiliates and neither
Issuing Bank nor any of its affiliates or any of its directors, officers or agents accept any responsibility or liability for the contents of this sales brochure.
Selling Restrictions for Securities
The Purchaser of the Securities represents and agrees that the Securities shall not be offered, advertised, sold or otherwise transferred, either directly or indirectly to
any person in violation of economic sanctions or wider restrictions applicable to either the Purchaser or the Issuer. The information contained herein does not
constitute an offer or invitation to purchase securities (the “Securities”) by anyone in any jurisdiction in which such offer or invitation is not authorized or to any person
to whom it is unlawful to make such offer or invitation. The distribution of this document and the offering or sale of the Securities may be prohibited or restricted by law
in some jurisdictions. The Securities may not be publicly offered, sold or delivered within or from the jurisdiction of any country, except in accordance with the
applicable laws and other legal provisions, and provided further that the Issuer does not incur any obligations. The Issuer has not undertaken any steps, nor will the
Issuer undertake any steps, aimed at making the public offering of the Securities or their possession or the marketing of offering documents related to the Securities
legal in such jurisdiction if this requires special measures to be taken.
EEA: The requirements for a public offer in any member state of the European Economic Area ("EEA Member State”) are not fulfilled. Consequently, the Securities
may not be publicly offered in any of the EEA Member States except as explicitly provided under the prospectus exemptions of Directive 2003/71/EC (as amended by
Directive 2010/73/EU, to the extent implemented in a relevant EEA Member State ("2010 Amending Directive"), the "EU Directive") with respect to inter alia (i) an offer
of securities addressed solely to qualified investors as defined in the EU Directive, and/or (ii) an offer of securities addressed to fewer than 100, or, if the EEA Member
State has implemented the relevant provisions of the 2010 Amending Directive, 150 natural or legal persons per EEA Member State other than qualified investors, and/
or (iii) an offer of securities addressed to investors who acquire securities for a total consideration of at least EUR 50,000, or, if the EEA Member State has
implemented the relevant provisions of the 2010 Amending Directive, EUR 100,000, and/or (iv) an offer of securities whose denomination per unit amounts to at least
EUR 50,000 or, if the Relevant Member State has implemented the relevant provisions of the 2010 Amending Directive, EUR 100,000.
United States of America: This document is not for distribution, directly or indirectly, in or into the United States of America (“United States”) or its possessions. This
document is not an offer to sell securities, or the solicitation of any offer to buy securities, nor shall there be any offer of securities in the United States or in any
jurisdiction in which such offer or sale would be unlawful. The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended
(“Securities Act”), and may not be offered or sold in the United States absent registration or exemption from registration under the Securities Act.
Secondary Market
The Issuing bank will endeavour to provide quotes under normal market conditions for trading purposes upon request, subject to a Bid-Offer spread of 1%. On the secondary market, traded prices will include any accrued interest ("dirty prices") and are available daily.
Sale trades will settle 2 days after the trade date.
Trade orders should be sent to [email protected]
All trades will be settled direct with Natixis’ Euroclear a/c 16139
Natixis
UK Titans 50-50 Memory Income Autocall February 2018
Factsheet
IDAD Limited is Authorised and Regulated by the Financial Conduct Authority FCA FRN 740499. No part of this publication may be reproduced, copied or distributed without the prior permission in writing of IDAD. Returns from the structured products are at risk in the event of any of the institutions who provide securities for these products default on their financial obligations. All investors should seek advice from a suitably authorised financial adviser and investment must be made via an authorised counterparty.